Corixa to Present at Invest Northwest, Roth Capital Partners and SG Cowen Conferences in March.Business Editors/Health/Medical Writers BIOWIRE2K SEATTLE--(BUSINESS WIRE)--March 5, 2003 Corixa Corporation (Nasdaq:CRXA), a developer of immunotherapeutics, announced today that the company's senior executives will provide an overview of programs at three investor conferences in March 2003. These conferences are the Washington Biotechnology & Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Association's (WBBA WBBA Wisconsin Bed and Breakfast Association WBBA Washington Biotechnology and Biomedical Association WBBA Wisconsin Breeding Bird Atlas WBBA World Beach Basketball Association WBBA Western Bird Banding Association ) Invest Northwest Conference on March 10, 2003, the 15th Annual Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services, Growth Stock Conference on March 17, 2003 and SG Cowen's 23rd Annual Health Care Conference on March 20, 2003. All conferences will be webcast live through the Investor's section of Corixa's website (http://www.corixa.com/default.asp?pid=invest). WBBA Invest Northwest Corixa will present at 2:00 pm PT, Monday, March 10 at the Bell Harbor Conference Center, Seattle, Washington. 15th Annual Roth Capital Partners Growth Stock Conference Corixa will present on Monday, March 17 at 11:00 am PT in the Aegean Room of the St. Regis Monarch Beach Resort and Spa, Dana Point, California Dana Point is a city located in southern Orange County, California. The population was 35,110 at the 2000 census. As one of the few harbors along the Orange County coast, and with ready access via California State Route 1, it is a popular local destination for surfing and is home . SG Cowen's 23rd Annual Health Care Conference Corixa will present on Thursday, March 20 from 10:15 to 11:00 am ET, and from 11:15 am to 12:00 pm. The conference will be held at the Marriott Copley Place Hotel, Boston, Massachusetts. About Corixa Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases Autoimmune diseases A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs. Mentioned in: Complement Deficiencies, Premature Menopause , cancer and infectious diseases by understanding and directing the immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. . Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. Corixa currently has multiple programs in clinical development, including several product candidates that have advanced to or through late stage clinical trials. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are Powered by Corixa(TM) technology with the goal of making its potential products available to patients around the world. Corixa was founded in 1994 and is headquartered in Seattle, with additional operations in Hamilton, Mont., and South San Francisco South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. . For more information, please visit Corixa's Web site at www.corixa.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion